{
  "meta": {
    "title": "40_Acute_Myeloid_Leukemia",
    "url": "https://brainandscalpel.vercel.app/40-acute-myeloid-leukemia-121ba03b.html",
    "scrapedAt": "2025-11-30T17:52:18.445Z"
  },
  "questions": [
    {
      "text": "34-year-old female presented with progressive pallor and organomegaly. Work up shows low Hb, platelet count of 25000/mm3. raised PT and aPTT. Peripheral smear is given. Which of the following fusion gene is affected?",
      "choices": [
        {
          "id": 0,
          "text": "PML RARA"
        },
        {
          "id": 1,
          "text": "RUNX1 RUNX1T1"
        },
        {
          "id": 2,
          "text": "IGH NSD2"
        },
        {
          "id": 3,
          "text": "BCR ABL"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct answer is a: PML RARA</strong></p>\n\n<ul>\n\t<li>Patient with features of blood caner is having low <span class=\"customMeta\" data-dictid=\"e7032bae7f1692777195d693722e54\">platelet</span> count with elevated PT and aPTT. This implies DIC which is seen in M3 AML. Acute promyelocytic <span class=\"customMeta\" data-dictid=\"4521dbf4b91692777191a73002bf98\">leukemia</span> has PML-RARA rearrangement.</li>\n</ul>\n\n<p><strong>Incorrect options</strong></p>\n\n<p>RUNX1–RUNX1T1 is associated with AML with t(8;21) (M2).</p>\n\n<p>IGH–NSD2 is associated with Lymphoid malignancies (rare).</p>\n\n<p>BCR–ABL is associated with CML or Ph+ ALL.</p>",
      "question_images": [
        "https://image.prepladder.com/content/E93f9uQgpw73m4esTLZz1755752602.png"
      ],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A 60-year-old man presents with recurrent episodes of bleeding from nose and progressive pallor. Peripheral smear shows the presence of cells shown below. Which of the following is the most common chromosomal abnormality seen in this condition?",
      "choices": [
        {
          "id": 0,
          "text": "t (8:21)"
        },
        {
          "id": 1,
          "text": "t (15:17)"
        },
        {
          "id": 2,
          "text": "t (14:18)"
        },
        {
          "id": 3,
          "text": "Inv (16)"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Correct answer is b: t (15:17) </strong></p>\n\n<ul>\n\t<li>Image shows <span class=\"customMeta\" data-dictid=\"da88d7f2211692777193037caba514\">myeloid</span> cells with Auer rods in the cytoplasm. This coupled with <span class=\"customMeta\" data-dictid=\"41e858bf2816927771836d46c619b9\">bleeding</span> manifestation implies association with <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> promyelocytic leukaemia (M3 AML). It occurs due to t (15:17) translocation.</li>\n</ul>\n\n<p><br />\n </p>",
      "question_images": [
        "https://image.prepladder.com/content/YQjUDZFxKZAnoEx8n8FM1755752631.png"
      ],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A 45-year-old male presents with fatigue, progressive pallor and recurrent nasal bleeds. Bone marrow aspiration shows 10% myeloblasts with abnormal eosinophils. Cytogenetic analysis reveals inv(16) (p13;q22). Which of the following is the most appropriate diagnosis?",
      "choices": [
        {
          "id": 0,
          "text": "Myelodysplastic syndrome"
        },
        {
          "id": 1,
          "text": "Acute myeloid leukemia"
        },
        {
          "id": 2,
          "text": "Chronic myelomonocytic leukemia"
        },
        {
          "id": 3,
          "text": "Chronic myeloid leukemia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Correct answer is b: Acute <span class=\"customMeta\" data-dictid=\"da88d7f2211692777193037caba514\">myeloid</span> <span class=\"customMeta\" data-dictid=\"4521dbf4b91692777191a73002bf98\">leukemia</span> </strong></p>\n\n<ul>\n\t<li>Marrow blast count of ≥20% is required, except for AML with the <span class=\"customMeta\" data-dictid=\"c64e3a661b1692777197afc2ff7bca\">recurrent</span> genetic abnormalities\n\t<ul>\n\t\t<li>t (15;17)</li>\n\t\t<li>t (8;21)</li>\n\t\t<li>inv (16)</li>\n\t\t<li>t (16;16)</li>\n\t</ul>\n\t</li>\n</ul>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A 60-year-old man presented with early satiety and abdominal pain. On examination grossly enlarged spleen and liver is palpable Work up shows low Hb with WBC-50000/mm3 and platelet count of 6 lac/cu.mm. Which of the following will cause this presentation?",
      "choices": [
        {
          "id": 0,
          "text": "t (9:22)"
        },
        {
          "id": 1,
          "text": "Del 1q"
        },
        {
          "id": 2,
          "text": "t (15:17)"
        },
        {
          "id": 3,
          "text": "Del 3q"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct answer is a: t (9:22) </strong></p>\n\n<ul>\n\t<li>Enlarged <span class=\"customMeta\" data-dictid=\"6a4861c8d71692777199aeb1d55c85\">spleen</span> with high TLC is feature of CML. The cause is Philadelphia <span class=\"customMeta\" data-dictid=\"7157c1f59916927771846116d74646\">chromosome</span> where a <span class=\"customMeta\" data-dictid=\"319b09474d169277718231e04c8898\">balanced translocation</span> between <span class=\"customMeta\" data-dictid=\"7157c1f59916927771846116d74646\">chromosome</span> 9 and 22 creates a bcr- abl1 <span class=\"customMeta\" data-dictid=\"a7dfeb385e1692777203302bcf142d\">fusion</span> gene causing <span class=\"customMeta\" data-dictid=\"ba6b77f29316927771807350f86ce2\">activation</span> of tyrosine <span class=\"customMeta\" data-dictid=\"9863da498e1692777190e1c6515b48\">kinase</span> and uncontrolled mitosis. CML in chronic phase has <span class=\"customMeta\" data-dictid=\"c6c363fec9169277719136fc0c76d7\">leucocytosis</span> with thrombocytosis.</li>\n</ul>\n\n<p> </p>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Which of the following chromosomal aberrations occur in topoisomerase II inhibitor–associated acute myeloid leukemia?",
      "choices": [
        {
          "id": 0,
          "text": "t (15:17)"
        },
        {
          "id": 1,
          "text": "inv16"
        },
        {
          "id": 2,
          "text": "11q23"
        },
        {
          "id": 3,
          "text": "t (8:21)"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Correct answer is c: 11q23</strong></p>\n\n<ul>\n\t<li><strong>Topoisomerase II inhibitor–associated</strong> <strong>leukaemia</strong> occurs 1–3 years after exposure, and affected individuals often have AML with <span class=\"customMeta\" data-dictid=\"7eae8f57ab16927771922b5f3d81e4\">monocytic</span> features and aberrations involving chromosome11q23.</li>\n\t<li><strong>Alkylating agent associated leukaemia</strong> occurs 4–6 years after exposure and have monosomy/aberrations in chromosomes 5 and 7.</li>\n</ul>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Which type of AML shows extensive infiltration of skin, soft tissues, gingiva and meninges?",
      "choices": [
        {
          "id": 0,
          "text": "AML with maturation"
        },
        {
          "id": 1,
          "text": "Acute promyelocytic leukemia"
        },
        {
          "id": 2,
          "text": "Acute myelomonocytic leukemia"
        },
        {
          "id": 3,
          "text": "Acute monocytic leukemia"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Correct answer is d: <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">Acute</span> <span class=\"customMeta\" data-dictid=\"7eae8f57ab16927771922b5f3d81e4\">monocytic</span> <span class=\"customMeta\" data-dictid=\"4521dbf4b91692777191a73002bf98\">leukemia</span> </strong></p>\n\n<ul>\n\t<li>Infiltration of skin and soft tissues called chloroma, <span class=\"customMeta\" data-dictid=\"e91ea8fa0c1692777188fbca424585\">gingival hyperplasia</span> and CNS leukaemia due to meningeal <span class=\"customMeta\" data-dictid=\"669bdcb3111692777190e018ae930e\">infiltration</span> is commonly seen with <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> <strong>monocytic </strong>leukaemia with 11q23 abnormalities.</li>\n</ul>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Which of the following genetic mutations is not responsible for AML",
      "choices": [
        {
          "id": 0,
          "text": "NPM1"
        },
        {
          "id": 1,
          "text": "FLT#-ITD"
        },
        {
          "id": 2,
          "text": "CEBPA"
        },
        {
          "id": 3,
          "text": "NOTCH1"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Correct answer is d: NOTCH1 </strong></p>\n\n<ul>\n\t<li>NPM1, FLT3-ITD, and CEBPA mutations are commonly seen in AML and influence <span class=\"customMeta\" data-dictid=\"e580b4033e169277719609af594c16\">prognosis</span> and treatment.</li>\n\t<li>NOTCH1 mutations are primarily associated with T-cell <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> lymphoblastic <span class=\"customMeta\" data-dictid=\"4521dbf4b91692777191a73002bf98\">leukemia</span> (T-ALL) and are not involved in AML pathogenesis.</li>\n</ul>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Arsenic trioxide is used for treatment of which of the following malignancy?",
      "choices": [
        {
          "id": 0,
          "text": "Acute promyelocytic leukemia"
        },
        {
          "id": 1,
          "text": "Acute myelomonocytic leukemia"
        },
        {
          "id": 2,
          "text": "Acute monocytic leukemia"
        },
        {
          "id": 3,
          "text": "Acute megakaryocytic leukemia"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct answer is a: Acute promyelocytic <span class=\"customMeta\" data-dictid=\"4521dbf4b91692777191a73002bf98\">leukemia</span> </strong></p>\n\n<ul>\n\t<li>All <span class=\"customMeta\" data-dictid=\"8da830779416927772004eec86224b\">trans</span> <span class=\"customMeta\" data-dictid=\"ca82227ce61692777197ab9d330931\">retinoic acid</span> and <span class=\"customMeta\" data-dictid=\"16769778ef16927771823ef4ef055e\">arsenic trioxide</span> are used for management of APL</li>\n</ul>\n\n<p><strong>Mechanism of action of <span class=\"customMeta\" data-dictid=\"16769778ef16927771823ef4ef055e\">Arsenic trioxide</span> </strong></p>\n\n<ol>\n\t<li><strong>Degradation of PML-RARA oncoprotein:</strong> It promotes ubiquitin-mediated proteasomal <span class=\"customMeta\" data-dictid=\"d395f610461692777185cbe8b8806d\">degradation</span> of the <span class=\"customMeta\" data-dictid=\"458e050fdc16927771809854c9fd53\">abnormal</span> PML-RARA <span class=\"customMeta\" data-dictid=\"a7dfeb385e1692777203302bcf142d\">fusion</span> protein that blocks differentiation.</li>\n\t<li><strong>Induction of apoptosis:</strong> ATO generates <span class=\"customMeta\" data-dictid=\"092583d1b41692777197a506409267\">reactive</span> oxygen species and mitochondrial damage, triggering programmed <span class=\"customMeta\" data-dictid=\"2f3a62230316927771846649e8b780\">cell death</span> of leukemic cells.</li>\n\t<li><strong>Promotion of differentiation:</strong> Similar to ATRA, ATO helps leukemic promyelocytes <span class=\"customMeta\" data-dictid=\"0472620c171692777192c655af9c57\">mature</span> into normal granulocytes.</li>\n</ol>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A 28-year-old female with acute promyelocytic leukemia is started on ATRA therapy. After 10 days, she develops fever, dyspnea, weight gain, and pulmonary infiltrates on chest X-ray. Which of the following is the most appropriate treatment for this complication?",
      "choices": [
        {
          "id": 0,
          "text": "Discontinue ATRA permanently"
        },
        {
          "id": 1,
          "text": "Initiate high-dose corticosteroids"
        },
        {
          "id": 2,
          "text": "Start broad-spectrum antibiotics"
        },
        {
          "id": 3,
          "text": "Urgent leukapheresis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Correct answer is b: Initiate high-dose corticosteroids </strong></p>\n\n<ul>\n\t<li>The patient has developed <strong>Differentiation Syndrome</strong>, a potentially life-threatening <span class=\"customMeta\" data-dictid=\"8a6b09beac1692777184b08a2b5766\">complication</span> caused by rapid <span class=\"customMeta\" data-dictid=\"55a682d72e16927771865bb4855ba3\">differentiation</span> and <span class=\"customMeta\" data-dictid=\"0ac01cc0c31692777185cae5f28175\">cytokine</span> release by <span class=\"customMeta\" data-dictid=\"f8aaf091221692777191f73e810e94\">malignant</span> cells.</li>\n\t<li>The syndrome is related to <span class=\"customMeta\" data-dictid=\"2b1931a185169277718065e3fa42dd\">adhesion</span> of differentiated <span class=\"customMeta\" data-dictid=\"c82360aadd16927771936d67fa30a4\">neoplastic</span> cells to the <span class=\"customMeta\" data-dictid=\"10e2dee19e1692777196673db90c23\">pulmonary</span> <span class=\"customMeta\" data-dictid=\"5e9945f4ca169277720145ab886b00\">vasculature</span> endothelium.</li>\n\t<li>Symptoms include fever, <span class=\"customMeta\" data-dictid=\"cfad80a0f716927771979aae100f95\">respiratory</span> distress, weight gain, pleural/pericardial effusions, and <span class=\"customMeta\" data-dictid=\"10e2dee19e1692777196673db90c23\">pulmonary</span> infiltrates. <strong>Early <span class=\"customMeta\" data-dictid=\"a3e96d80e9169277718551158bbcd4\">corticosteroid</span> therapy with dexamethasone</strong> is the cornerstone of treatment and can be continued along with ATRA.</li>\n</ul>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Which of the following clinical features is/are seen in patient with AML\n\n\n\tGum hypertrophy\n\tSkin infiltration\n\tLower extremity weakness\n\tPapilledema",
      "choices": [
        {
          "id": 0,
          "text": "1,2"
        },
        {
          "id": 1,
          "text": "1,2,3"
        },
        {
          "id": 2,
          "text": "1,3,4"
        },
        {
          "id": 3,
          "text": "1,2,3,4"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Correct answer is d: 1,2,3,4</strong></p>\n\n<ul>\n\t<li>GUM <span class=\"customMeta\" data-dictid=\"3baac9012a1692777189cb4dc70c04\">hypertrophy</span> (leukemic infiltration, most common in <span class=\"customMeta\" data-dictid=\"7eae8f57ab16927771922b5f3d81e4\">monocytic</span> leukemia)</li>\n\t<li>Skin <span class=\"customMeta\" data-dictid=\"669bdcb3111692777190e018ae930e\">infiltration</span> or nodules ( <span class=\"customMeta\" data-dictid=\"4521dbf4b91692777191a73002bf98\">leukemia</span> infiltration, most common in <span class=\"customMeta\" data-dictid=\"7eae8f57ab16927771922b5f3d81e4\">monocytic</span> leukemia)</li>\n\t<li>Back pain, lower <span class=\"customMeta\" data-dictid=\"c8ed8e0fb61692777187c860f7056f\">extremity</span> weakness (spinal <span class=\"customMeta\" data-dictid=\"f56da4c63c1692777188101e40d3ba\">granulocytic</span> sarcoma, most likely in t(8:21) patients)</li>\n\t<li>Papilledema is explained by CNS leukemia</li>\n</ul>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    }
  ]
}